Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
7.8K Views
•
09:38 min
•
June 26th, 2019
DOI :
June 26th, 2019
•Chapters in this video
0:04
Title
0:38
Initial Afatinib PC-9 Cell Exposure Determination by 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) Assay
1:46
Continuous Afatinib Exposure
3:01
PC-9 Cell Growth Curve Determination
3:46
Epidermal Growth Factor Receptor (EGFR) Genomic DNA Alteration Evaluation
4:53
Epidermal Growth Factor Receptor (EGFR) Protein Alteration Evaluation
7:39
Results: Afatinib-resistant Cell Characterization
8:59
Conclusion
Related Videos
Lung Tumor Cell Recruitment Assay
5.1K Views
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
8.7K Views
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
7.0K Views
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
9.2K Views
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
16.5K Views
Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
10.2K Views
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
9.7K Views
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
6.8K Views
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
6.4K Views
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
11.2K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved